Immunohistochemical investigation of cell cycle and apoptosis regulators (Survivin, β-Catenin, P53, Caspase 3) in canine appendicular osteosarcoma

<p>Abstract</p> <p>Background</p> <p>Osteosarcoma (OSA) represents the most common canine primary bone tumour. Despite several pathways have been investigated so far, few molecules have been identified as prognostic tools or potential therapeutic targets, and there is s...

Full description

Bibliographic Details
Main Authors: Bongiovanni Laura, Mazzocchetti Francesca, Malatesta Daniela, Romanucci Mariarita, Ciccarelli Andrea, Buracco Paolo, De Maria Raffaella, Palmieri Chiara, Martano Marina, Morello Emanuela, Maniscalco Lorella, Salda Leonardo
Format: Article
Language:English
Published: BMC 2012-06-01
Series:BMC Veterinary Research
Online Access:http://www.biomedcentral.com/1746-6148/8/78
_version_ 1811275971476586496
author Bongiovanni Laura
Mazzocchetti Francesca
Malatesta Daniela
Romanucci Mariarita
Ciccarelli Andrea
Buracco Paolo
De Maria Raffaella
Palmieri Chiara
Martano Marina
Morello Emanuela
Maniscalco Lorella
Salda Leonardo
author_facet Bongiovanni Laura
Mazzocchetti Francesca
Malatesta Daniela
Romanucci Mariarita
Ciccarelli Andrea
Buracco Paolo
De Maria Raffaella
Palmieri Chiara
Martano Marina
Morello Emanuela
Maniscalco Lorella
Salda Leonardo
author_sort Bongiovanni Laura
collection DOAJ
description <p>Abstract</p> <p>Background</p> <p>Osteosarcoma (OSA) represents the most common canine primary bone tumour. Despite several pathways have been investigated so far, few molecules have been identified as prognostic tools or potential therapeutic targets, and there is still the need to find out molecular pathways with specific influence over OSA progression to facilitate earlier prognosis and treatment.</p> <p>Aims of the present study were to evaluate the immunohistochemical pattern and levels of expression of a panel of molecules (survivin, β-catenin, caspase 3 -inactive and active forms- and p53) involved in cell cycle and apoptosis regulation in canine OSA samples, known to be of interest in the study also of human OSA, and to detect specific relations among them and with histological tumour grade, disease free interval (DFI) and overall survival (OS).</p> <p>Results</p> <p>Nuclear β-catenin immunostaining was detected in normal osteoblasts adjacent to the tumour, and in 47% of the cases. Cytoplasmic and/or membranous immunostaining were also observed. Nuclear survivin and p53 positive cells were found in all cases. Moderate/high cytoplasmic β-catenin expression (≥10% positive cells) was significantly associated with the development of metastasis (P = 0.014); moderate/high nuclear p53 expression (≥10% positive cells) was significantly associated with moderate/high histological grade (P = 0.017) and shorter OS (P = 0.049). Moderate/high nuclear survivin expression (≥15% positive cells) showed a tendency toward a longer OS (P = 0,088).</p> <p>Conclusions</p> <p>The present results confirmed p53 as negative prognostic marker, while suggested survivin as a potential positive prognostic indicator, rather than indicative of a poor prognosis. The detection of nuclear β-catenin immunostaining in normal osteoblasts and the absent/low expression in most of the OSAs, suggested that this pathway could not play a major role in oncogenic transformation of canine osteoblasts. Further studies are needed to confirm these hypotheses.</p>
first_indexed 2024-04-12T23:48:14Z
format Article
id doaj.art-879d33dfea3a4b67ae4c08c2a1b56b48
institution Directory Open Access Journal
issn 1746-6148
language English
last_indexed 2024-04-12T23:48:14Z
publishDate 2012-06-01
publisher BMC
record_format Article
series BMC Veterinary Research
spelling doaj.art-879d33dfea3a4b67ae4c08c2a1b56b482022-12-22T03:11:48ZengBMCBMC Veterinary Research1746-61482012-06-01817810.1186/1746-6148-8-78Immunohistochemical investigation of cell cycle and apoptosis regulators (Survivin, β-Catenin, P53, Caspase 3) in canine appendicular osteosarcomaBongiovanni LauraMazzocchetti FrancescaMalatesta DanielaRomanucci MariaritaCiccarelli AndreaBuracco PaoloDe Maria RaffaellaPalmieri ChiaraMartano MarinaMorello EmanuelaManiscalco LorellaSalda Leonardo<p>Abstract</p> <p>Background</p> <p>Osteosarcoma (OSA) represents the most common canine primary bone tumour. Despite several pathways have been investigated so far, few molecules have been identified as prognostic tools or potential therapeutic targets, and there is still the need to find out molecular pathways with specific influence over OSA progression to facilitate earlier prognosis and treatment.</p> <p>Aims of the present study were to evaluate the immunohistochemical pattern and levels of expression of a panel of molecules (survivin, β-catenin, caspase 3 -inactive and active forms- and p53) involved in cell cycle and apoptosis regulation in canine OSA samples, known to be of interest in the study also of human OSA, and to detect specific relations among them and with histological tumour grade, disease free interval (DFI) and overall survival (OS).</p> <p>Results</p> <p>Nuclear β-catenin immunostaining was detected in normal osteoblasts adjacent to the tumour, and in 47% of the cases. Cytoplasmic and/or membranous immunostaining were also observed. Nuclear survivin and p53 positive cells were found in all cases. Moderate/high cytoplasmic β-catenin expression (≥10% positive cells) was significantly associated with the development of metastasis (P = 0.014); moderate/high nuclear p53 expression (≥10% positive cells) was significantly associated with moderate/high histological grade (P = 0.017) and shorter OS (P = 0.049). Moderate/high nuclear survivin expression (≥15% positive cells) showed a tendency toward a longer OS (P = 0,088).</p> <p>Conclusions</p> <p>The present results confirmed p53 as negative prognostic marker, while suggested survivin as a potential positive prognostic indicator, rather than indicative of a poor prognosis. The detection of nuclear β-catenin immunostaining in normal osteoblasts and the absent/low expression in most of the OSAs, suggested that this pathway could not play a major role in oncogenic transformation of canine osteoblasts. Further studies are needed to confirm these hypotheses.</p>http://www.biomedcentral.com/1746-6148/8/78
spellingShingle Bongiovanni Laura
Mazzocchetti Francesca
Malatesta Daniela
Romanucci Mariarita
Ciccarelli Andrea
Buracco Paolo
De Maria Raffaella
Palmieri Chiara
Martano Marina
Morello Emanuela
Maniscalco Lorella
Salda Leonardo
Immunohistochemical investigation of cell cycle and apoptosis regulators (Survivin, β-Catenin, P53, Caspase 3) in canine appendicular osteosarcoma
BMC Veterinary Research
title Immunohistochemical investigation of cell cycle and apoptosis regulators (Survivin, β-Catenin, P53, Caspase 3) in canine appendicular osteosarcoma
title_full Immunohistochemical investigation of cell cycle and apoptosis regulators (Survivin, β-Catenin, P53, Caspase 3) in canine appendicular osteosarcoma
title_fullStr Immunohistochemical investigation of cell cycle and apoptosis regulators (Survivin, β-Catenin, P53, Caspase 3) in canine appendicular osteosarcoma
title_full_unstemmed Immunohistochemical investigation of cell cycle and apoptosis regulators (Survivin, β-Catenin, P53, Caspase 3) in canine appendicular osteosarcoma
title_short Immunohistochemical investigation of cell cycle and apoptosis regulators (Survivin, β-Catenin, P53, Caspase 3) in canine appendicular osteosarcoma
title_sort immunohistochemical investigation of cell cycle and apoptosis regulators survivin β catenin p53 caspase 3 in canine appendicular osteosarcoma
url http://www.biomedcentral.com/1746-6148/8/78
work_keys_str_mv AT bongiovannilaura immunohistochemicalinvestigationofcellcycleandapoptosisregulatorssurvivinbcateninp53caspase3incanineappendicularosteosarcoma
AT mazzocchettifrancesca immunohistochemicalinvestigationofcellcycleandapoptosisregulatorssurvivinbcateninp53caspase3incanineappendicularosteosarcoma
AT malatestadaniela immunohistochemicalinvestigationofcellcycleandapoptosisregulatorssurvivinbcateninp53caspase3incanineappendicularosteosarcoma
AT romanuccimariarita immunohistochemicalinvestigationofcellcycleandapoptosisregulatorssurvivinbcateninp53caspase3incanineappendicularosteosarcoma
AT ciccarelliandrea immunohistochemicalinvestigationofcellcycleandapoptosisregulatorssurvivinbcateninp53caspase3incanineappendicularosteosarcoma
AT buraccopaolo immunohistochemicalinvestigationofcellcycleandapoptosisregulatorssurvivinbcateninp53caspase3incanineappendicularosteosarcoma
AT demariaraffaella immunohistochemicalinvestigationofcellcycleandapoptosisregulatorssurvivinbcateninp53caspase3incanineappendicularosteosarcoma
AT palmierichiara immunohistochemicalinvestigationofcellcycleandapoptosisregulatorssurvivinbcateninp53caspase3incanineappendicularosteosarcoma
AT martanomarina immunohistochemicalinvestigationofcellcycleandapoptosisregulatorssurvivinbcateninp53caspase3incanineappendicularosteosarcoma
AT morelloemanuela immunohistochemicalinvestigationofcellcycleandapoptosisregulatorssurvivinbcateninp53caspase3incanineappendicularosteosarcoma
AT maniscalcolorella immunohistochemicalinvestigationofcellcycleandapoptosisregulatorssurvivinbcateninp53caspase3incanineappendicularosteosarcoma
AT saldaleonardo immunohistochemicalinvestigationofcellcycleandapoptosisregulatorssurvivinbcateninp53caspase3incanineappendicularosteosarcoma